Fenway Cohort affiliated with (North American- AIDS Cohort Collaboration on Research and Design (NA-ACCORD))

  • Principal Investigator(s): Kenneth Mayer, MD
  • Study Contact: Chris Grasso, MPH, 617-927-6018, cgrasso@fenwayhealth.org
  • Description of Subjects: Fenway Health medical patients who have had at least 2 HIV primary care visits at Fenway in a 12 month period and are 18 years or older
  • Location (Domestic vs. International): Fenway has participants from all over the New England geographic area. Fenway's facilities are located throughout Boston, MA.
  • Enrollment Period: 1997 to present (ongoing)
  • Enrollment Goal: Presently, Fenway has over 2,600 participants. Enrollment is ongoing.
  • Key Exclusion and Inclusion Criteria: Inclusion criteria: HIV-infected persons who are 18 years or older and have had at least 2 HIV primary care visits at Fenway in a 12 month period; and vital statistics, gender, year of birth, and first visit must be known . Exclusions: transgender, tran
  • Available Biological Specimens: 
    • Blood, serum, or plasma
    • Peripheral Blood Mononuclear Cells
    • Other (Cell Pellets)
  • How to Request Access: Email study contact person directly
  • Available Data Description: Demographics, risk factor, death data and longitudinal lab values (including CD4 and viral load), diagnosis, medication, and encounters
  • Optional Additional Comments: Fenway was accepted into the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) database research project in 2011. NA-ACCORD is part of the International epidemiologic Databases to Evaluate AIDS (IeDEA) which began in 2006. Comprised of 25 collaborating cohorts, NA-ACCORD is designed to be widely representative of HIV care in the United States and Canada. NA-ACCORD, with Johns Hopkins University as the lead, is one of seven regional HIV collaborations supported by the NIH as part of the International Epidemiologic Databases to Evaluate of AIDS (IeDEA).
See also: Blood, serum, and plasma, Peripheral Blood Mononuclear Cells, HIV+, Fenway Health, Studies > 1000 Participants, Studies Started Pre-2005, Domestic, Ken Mayer, Multi-site Networks